Three biotech stocks riding the AI wave like none other
FDA okays Daiichi Sankyo’s Vanflyta for first-line AML
ADC discontinues Zynlonta trial in DLBCL after seven deaths
Sleepless nights for 500 Idorsia staff as biotech halves cash burn to outlast weak insomnia drug sales
*please scroll down for all the latest news*
